Literature DB >> 2506161

Observations of visual sensations produced by Cerenkov radiation from high-energy electrons.

K D Steidley1, R M Eastman, R J Stabile.   

Abstract

Ten cancer patients whose eyes were therapeutically irradiated with 6-18 MeV electrons reported visual light sensations. Nine reported seeing blue light and one reported seeing white light. Controls reported seeing no light. Additionally, tests with patients ruled out the x-ray contamination of the electron beam as being important. The photon yield due to Cerenkov radiation produced by radium and its daughters for both electrons and gamma rays was calculated; it was found to account for a turn-of-the-century human observation of the "radium" phosphene. We conclude that the dominant mechanism of this phosphene is Cerenkov radiation, primarily from betas. From our own patient data, based on the color seen and the Cerenkov production rates, we conclude that the dominant mechanism is Cerenkov radiation and that high-energy electrons are an example of particle induced visual sensations.

Entities:  

Mesh:

Year:  1989        PMID: 2506161     DOI: 10.1016/0360-3016(89)90125-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Review of biomedical Čerenkov luminescence imaging applications.

Authors:  Kaveh Tanha; Ali Mahmoud Pashazadeh; Brian W Pogue
Journal:  Biomed Opt Express       Date:  2015-07-28       Impact factor: 3.732

Review 2.  Optical and x-ray technology synergies enabling diagnostic and therapeutic applications in medicine.

Authors:  Brian W Pogue; Brian C Wilson
Journal:  J Biomed Opt       Date:  2018-10       Impact factor: 3.170

3.  Unusual visual and olfactory perceptions during radiotherapy sessions: an investigation of the organs responsible.

Authors:  N Hara; A Isobe; K Yamada; Y Kosugi; M Oshima; T Kawamoto; N Shikama; K Sasai
Journal:  J Radiat Res       Date:  2021-07-10       Impact factor: 2.724

4.  Extraretinal induced visual sensations during IMRT of the brain.

Authors:  Timo Wilhelm-Buchstab; Barbara Myrthe Buchstab; Christina Leitzen; Stephan Garbe; Thomas Müdder; Susanne Oberste-Beulmann; Alois Martin Sprinkart; Birgit Simon; Michael Nelles; Wolfgang Block; Felix Schoroth; Hans Heinz Schild; Heinrich Schüller
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

Review 5.  Mechanisms of phosphenes in irradiated patients.

Authors:  Thibaud Mathis; Stephane Vignot; Cecila Leal; Jean-Pierre Caujolle; Celia Maschi; Martine Mauget-Faÿsse; Laurent Kodjikian; Stéphanie Baillif; Joel Herault; Juliette Thariat
Journal:  Oncotarget       Date:  2017-06-28

6.  Unusual olfactory perception during radiation sessions for primary brain tumors: a retrospective study.

Authors:  Mika Obinata; Kana Yamada; Keisuke Sasai
Journal:  J Radiat Res       Date:  2019-11-22       Impact factor: 2.724

7.  Light flashes during proton and photon radiotherapy: A multicenter prospective observational study.

Authors:  Masashi Mizumoto; Yoshiko Oshiro; Toshio Miyamoto; Taisuke Sumiya; Motohiro Murakami; Keiichiro Baba; Shosei Shimizu; Takashi Iizumi; Haruko Numajiri; Kei Nakai; Toshiyuki Okumura; Kazushi Maruo; Takeji Sakae; Hideyuki Sakurai
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2021-11-24

8.  Light flash and odor during proton beam therapy for pediatric patients: a prospective observational study.

Authors:  Masashi Mizumoto; Yoshiko Oshiro; Toshio Miyamoto; Taisuke Sumiya; Keiichiro Baba; Motohiro Murakami; Shosei Shimizu; Takashi Iizumi; Takashi Saito; Hirokazu Makishima; Haruko Numajiri; Kei Nakai; Toshiyuki Okumura; Kazushi Maruo; Takeji Sakae; Hideyuki Sakurai
Journal:  Front Oncol       Date:  2022-08-01       Impact factor: 5.738

9.  fMRI of retina-originated phosphenes experienced by patients with Leber congenital amaurosis.

Authors:  Manzar Ashtari; Laura Cyckowski; Alborz Yazdi; Amanda Viands; Kathleen Marshall; István Bókkon; Albert Maguire; Jean Bennett
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.